CMS-D001 50mg

DRUG2 trials

Sponsors

Dermavon Holdings Limited

Conditions

Moderate to Severe Atopic DermatitisModerate to Severe Plaque Psoriasis

Phase 2

A Clinical Study Evaluating the Efficacy and Safety of CMS-D001 Tablets in the Treatment of Adult Patients With Moderate to Severe Plaque-type Psoriasis

Not yet recruitingNCT07432854

Dermavon Holdings LimitedModerate to Severe Plaque Psoriasis

Start: 2026-03-03End: 2028-07-30Target: 540Updated: 2026-02-25

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase Ⅱ Clinical Study to Evaluate the Efficacy and Safety of CMS-D001 in Adult Patients With Moderate to Severe Atopic Dermatitis

Not yet recruitingNCT07465120

Dermavon Holdings LimitedModerate to Severe Atopic Dermatitis

Start: 2026-03-20End: 2027-05-31Target: 160Updated: 2026-03-11